From the Centre for Human Psychopharmacology (A.P., L.K., D.L.) the Centre for Mental Health (W.W.), Swinburne University of Technology, Melbourne, Australia the Faculty of Information Technology, Monash University, Melbourne, Australia (L.K.) the Department of Anaesthesia and Pain Management, St. Vincent's Hospital Melbourne, Melbourne, Australia (J.C., S.M.) the School of Pharmacy, The University of Auckland, New Zealand (S.M.) the Department of Medicine, The University of Melbourne, Parkville, Melbourne, Australia (D.L.).
Anesthesiology. 2020 May;132(5):1017-1033. doi: 10.1097/ALN.0000000000003169.
Investigations of the electrophysiology of gaseous anesthetics xenon and nitrous oxide are limited revealing inconsistent frequency-dependent alterations in spectral power and functional connectivity. Here, the authors describe the effects of sedative, equivalent, stepwise levels of xenon and nitrous oxide administration on oscillatory source power using a crossover design to investigate shared and disparate mechanisms of gaseous xenon and nitrous oxide anesthesia.
Twenty-one healthy males underwent simultaneous magnetoencephalography and electroencephalography recordings. In separate sessions, sedative, equivalent subanesthetic doses of gaseous anesthetic agents nitrous oxide and xenon (0.25, 0.50, and 0.75 equivalent minimum alveolar concentration-awake [MACawake]) and 1.30 MACawake xenon (for loss of responsiveness) were administered. Source power in various frequency bands were computed and statistically assessed relative to a conscious/pre-gas baseline.
Observed changes in spectral-band power (P < 0.005) were found to depend not only on the gas delivered, but also on the recording modality. While xenon was found to increase low-frequency band power only at loss of responsiveness in both source-reconstructed magnetoencephalographic (delta, 208.3%, 95% CI [135.7, 281.0%]; theta, 107.4%, 95% CI [63.5, 151.4%]) and electroencephalographic recordings (delta, 260.3%, 95% CI [225.7, 294.9%]; theta, 116.3%, 95% CI [72.6, 160.0%]), nitrous oxide only produced significant magnetoencephalographic high-frequency band increases (low gamma, 46.3%, 95% CI [34.6, 57.9%]; high gamma, 45.7%, 95% CI [34.5, 56.8%]). Nitrous oxide-not xenon-produced consistent topologic (frontal) magnetoencephalographic reductions in alpha power at 0.75 MACawake doses (44.4%; 95% CI [-50.1, -38.6%]), whereas electroencephalographically nitrous oxide produced maximal reductions in alpha power at submaximal levels (0.50 MACawake, -44.0%; 95% CI [-48.1,-40.0%]).
Electromagnetic source-level imaging revealed widespread power changes in xenon and nitrous oxide anesthesia, but failed to reveal clear universal features of action for these two gaseous anesthetics. Magnetoencephalographic and electroencephalographic power changes showed notable differences which will need to be taken into account to ensure the accurate monitoring of brain state during anaesthesia.
对气态麻醉剂氙气和一氧化二氮的电生理学研究有限,揭示了频谱功率和功能连接的不一致的频率依赖性改变。在这里,作者描述了镇静作用、等效、逐步递增水平的氙气和一氧化二氮给药对使用交叉设计研究气态氙气和一氧化二氮麻醉的共享和不同机制的振荡源功率的影响。
21 名健康男性接受了同时进行的脑磁图和脑电图记录。在单独的疗程中,给予了镇静作用、等效亚麻醉剂量的气态麻醉剂一氧化二氮和氙气(0.25、0.50 和 0.75 等效最低肺泡浓度-清醒[MACawake])和 1.30 MACawake 氙气(用于失去反应性)。计算了各种频带中的源功率,并相对于清醒/预气体基线进行了统计学评估。
观察到的频谱带功率变化(P < 0.005)不仅取决于所输送的气体,还取决于记录方式。虽然仅在失去反应性时,氙气才会增加源重建脑磁图(delta,208.3%,95%CI[135.7, 281.0%];theta,107.4%,95%CI[63.5, 151.4%])和脑电图记录(delta,260.3%,95%CI[225.7, 294.9%];theta,116.3%,95%CI[72.6, 160.0%])中的低频带功率,但一氧化二氮仅产生显著的脑磁图高频带增加(低伽马,46.3%,95%CI[34.6, 57.9%];高伽马,45.7%,95%CI[34.5, 56.8%])。一氧化二氮而不是氙气在 0.75 MACawake 剂量时产生一致的额磁图 alpha 功率拓扑(额叶)减少(44.4%;95%CI[-50.1,-38.6%]),而脑电图上的一氧化二氮在亚最大水平(0.50 MACawake)时产生最大的 alpha 功率减少,为-44.0%;95%CI[-48.1,-40.0%])。
电磁源水平成像揭示了氙气和一氧化二氮麻醉中的广泛功率变化,但未能揭示这两种气态麻醉剂的明确普遍作用特征。磁图和脑电图的功率变化显示出明显的差异,这需要加以考虑,以确保在麻醉期间准确监测脑状态。